MDDRX
Price
$10.30
Change
+$0.09 (+0.88%)
Updated
Sep 4 closing price
Net Assets
319.75M
VIVAX
Price
$71.21
Change
-$0.23 (-0.32%)
Updated
Sep 5 closing price
Net Assets
202.84B
Interact to see
Advertisement

MDDRX vs VIVAX

Header iconMDDRX vs VIVAX Comparison
Open Charts MDDRX vs VIVAXBanner chart's image
MassMutual Diversified Value R4
Price$10.30
Change+$0.09 (+0.88%)
VolumeN/A
Net Assets319.75M
Vanguard Value Index I
Price$71.21
Change-$0.23 (-0.32%)
VolumeN/A
Net Assets202.84B
MDDRX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MDDRX vs. VIVAX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDDRX is a StrongBuy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 203B vs. MDDRX (320M). VIVAX pays higher dividends than MDDRX: VIVAX (1.99) vs MDDRX (1.26). MDDRX was incepted earlier than VIVAX: MDDRX (11 years) vs VIVAX (33 years). MDDRX (1.09) is less costly to investors than VIVAX (0.17). MDDRX is a more actively managed with annual turnover of: 46.00 vs. VIVAX (9.00). MDDRX has a lower initial minimum investment than VIVAX: MDDRX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 8.09 vs. MDDRX (-18.71). VIVAX return over 5 years is better than : 70.73 vs. MDDRX (12.01).
MDDRXVIVAXMDDRX / VIVAX
Total Expense Ratio1.090.17641%
Annual Report Gross Expense Ratio1.090.17641%
Fund Existence11 years33 years-
Gain YTD11.1118.193136%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets320M203B0%
Annual Yield % from dividends1.261.9964%
Returns for 1 year-18.718.09-231%
Returns for 3 years-6.8537.08-18%
Returns for 5 years12.0170.7317%
Returns for 10 years-12.35132.39-9%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RNWBX86.970.63
+0.73%
American Funds New World R2
GCMCX30.20N/A
N/A
Goldman Sachs Mid Cap Value C
GVIRX18.28N/A
N/A
Goldman Sachs US Eq Div and Premium Inv
WELNX10.56N/A
N/A
William Blair Emerging Mkts Ldrs N
RLAIX21.11N/A
N/A
T. Rowe Price Latin America I